In vitro evaluations of U-76,252 (CS-807): Antimicrobial spectrum, beta-lactamase stability, and enzyme inhibition
- 1 December 1987
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 8 (4), 245-249
- https://doi.org/10.1016/0732-8893(87)90056-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolatesDiagnostic Microbiology and Infectious Disease, 1987
- BMY 28100, a new oral cephalosporinAntimicrobial Agents and Chemotherapy, 1987
- Studies on orally active cephalosporin esters.The Journal of Antibiotics, 1987
- Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolatesAntimicrobial Agents and Chemotherapy, 1986
- Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiencyAntimicrobial Agents and Chemotherapy, 1986
- In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibioticAntimicrobial Agents and Chemotherapy, 1984
- Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteersAntimicrobial Agents and Chemotherapy, 1984
- Comparative beta-lactamase hydrolysis of and inhibition by 7-aminothiazolyl alpha-methoxyimino cephalosporinsInfection, 1982
- In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporinAntimicrobial Agents and Chemotherapy, 1981
- The β-Lactamases of Gram-Negative Bacteria and their Possible Physiological RolePublished by Elsevier ,1973